Based on 2 analysts offering 12 month price targets for Pharming Group Nv
Min Forecast
$37.00+211.71%
Avg Forecast
$37.50+215.92%
Max Forecast
$38.00+220.13%
Should I buy or sell PHAR stock?
Based on 2 analysts offering ratings for Pharming Group Nv.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although PHAR's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates PHAR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More
Be the first to know when Wall Street analysts revise their PHAR stock forecasts and price targets.
Is Pharming Group Nv Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: PHAR) stock is to Strong Buy PHAR stock.
Out of 2 analysts, 1 (50%) are recommending PHAR as a Strong Buy, 1 (50%) are recommending PHAR as a Buy, 0 (0%) are recommending PHAR as a Hold, 0 (0%) are recommending PHAR as a Sell, and 0 (0%) are recommending PHAR as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year PHAR price target, the average PHAR price target is $37.50, with the highest PHAR stock price forecast at $38.00 and the lowest PHAR stock price forecast at $37.00.
On average, Wall Street analysts predict that Pharming Group Nv's share price could reach $37.50 by Sep 22, 2027. The average Pharming Group Nv stock price prediction forecasts a potential upside of 215.92% from the current PHAR share price of $11.87.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.